Have a personal or library account? Click to login
Impact of the Severity of Liver Injury in COVID-19 Patients Admitted to an Intensive Care Unit During the SARS-CoV2 Pandemic Outbreak Cover

Impact of the Severity of Liver Injury in COVID-19 Patients Admitted to an Intensive Care Unit During the SARS-CoV2 Pandemic Outbreak

Open Access
|Aug 2021

References

  1. Fan Z, Chen L, Li J et al. Clinical features of COVID-19-related liver functional abnormality. Clin. Gastroenterol. Hepatol 2020;18(7):1561-6.
  2. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
  3. http://www.ms.ro/coronavirus-covid-19/
  4. https://www.worldometers.info/coronavirus/#countries
  5. Qingxian C, Deliang H, Hong Y, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020; Sep: 566-74. doi:/10.1016/j.jhep.2020.04.006
  6. Wang D, Hu B, Hu C,et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA.2020; 323 (11): 1061-1069. doi:10.1001/jama.2020.1585
  7. Xiaolong Q, Chuan L, Jiang Z, et al. Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury. J Hepatol. 2020; 73(2): 455–458. doi: 10.1016/j.jhep.2020.04.010
  8. Andrade RJ, Chalasani N, Bjornsson ES, et al. Drug-induced liver injury. Nature Reviews Disease Primers. 2019; 5(1): 1-22.
  9. Chaolin H, Yeming W, Xingwang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.The Lancet. 2020; 395.10223: 497-506. https://doi. org/10.1016/S0140-6736(20)30183-5
  10. Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International immunopharmacology. 2020;106504. https://doi.org/10.1016/j.intimp.2020.106504
  11. Henry BM, Santos de Oliveira MH, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2020; 58.7: 1021-1028. https://doi. org/10.1515/cclm-2020-0369
  12. Yueying L, Xiao SY. Hepatic involvement in COVID‐19 patients: pathology, pathogenesis and clinical implications. Journal of medical virology. 2020; https://doi.org/10.1002/jmv.25973
  13. Wiersinga WJ, Rhodes A, Cheng CA, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. Jama. 2020; 324.8: 782-793. doi:10.1001/jama.2020.12839
  14. Gupta A, Mandhavan M, Landry D, et al. Extrapulmonary manifestations of COVID-19. Nature medicine. 2020; 26.7: 1017-1032. https://doi.org/10.1038/s41591-020-0968-3.
  15. Bertolini A, Van de Peppel PI, Bodewes F et al. Abnormal liver function tests in COVID‐19 patients: relevance and potential pathogenesis. Hepatology. 2020; 72(5):1864-1872 https://doi.org/10.1002/hep.31480
  16. Bloom PP, Trisha SP, Viveiros K. We know liver biochemistries are elevated in COVID-19, but should we be concerned?. Clinical Gastroenterology and Hepatology. 2020; 18.10: 23842385. https://doi.org/10.1016/j.cgh.2020.05.018
  17. Alqahtani SA, Jörn MS. Liver injury in COVID-19: The current evidence. United European Gastroenterology Journal. 2020; 8.5: 509-519. https://doi.org/10.1177/2050640620924157
  18. Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists should know. Annals of Hepatology. 2020; 19(4):353-358
  19. Parohan M, Sajad Y, Asal S. Liver injury is associated with severe Coronavirus disease 2019 (COVID‐19) infection: a systematic review and meta‐analysis of retrospective studies. Hepatology Research.2020; 50(8):924-935. https://doi.org/10.1111/hepr.13510
  20. Boettler T, Newsome PN, Mondelli MU, et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Reports. 2020; 2(3):100113. https://doi. org/10.1016/j.jhepr.2020.100113
  21. Jiang S , Wang R, Li L, et al. Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Frontiers in medicine. 2020; 7:347. https://doi.org/10.3389/fmed.2020.00347
  22. Bubenek S, Filipescu D, Grigoras I, et al. Ghid Societatea Romană de Anestezie și Terapie Intensivă – Terapia Intensivă a pacientului critic cu boală COVID-19 in secțiile ATI .2020. pp.30-38
  23. Zheng Y, Song B. COVID-19 related liver injury: call for international consensus. Clinical Gastroenterology and Hepatology. 2020; 18(12): 2848–2851. https://doi. org/10.1016/j.cgh.2020.05.
DOI: https://doi.org/10.2478/jccm-2021-0021 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 211 - 216
Submitted on: Nov 30, 2020
|
Accepted on: Jun 27, 2021
|
Published on: Aug 5, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Adina Roman, Septimiu Moldovan, Ario Santini, Mircea Stoian, Daniela Dobru, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.